{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:42:11Z","timestamp":1782225731643,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020948","name":"AstraZeneca M\u00f6lndal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5nes universitetssjukhus Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.hlc.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T15:33:12Z","timestamp":1681140792000},"page":"702-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction"],"prefix":"10.1016","volume":"32","author":[{"given":"Kristina","family":"Torngren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5921-3786","authenticated-orcid":false,"given":"Rebecca","family":"Rylance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ming","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Svedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-5766","authenticated-orcid":false,"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hlc.2023.03.010_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CRD.0b013e3182099d86","article-title":"Ticagrelor: a novel reversible oral antiplatelet agent","volume":"19","author":"Nawarskas","year":"2011","journal-title":"Cardiol Rev"},{"issue":"23","key":"10.1016\/j.hlc.2023.03.010_bib2","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hlc.2023.03.010_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1074248411410883","article-title":"Ticagrelor inhibits adenosine uptake in\u00a0vitro and enhances adenosine-mediated hyperemia responses in a canine model","volume":"17","author":"van Giezen","year":"2012","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.hlc.2023.03.010_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2013.09.067","article-title":"Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome","volume":"63","author":"Bonello","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2023.03.010_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbrc.2012.01.093","article-title":"Ticagrelor induces adenosine triphosphate release from human red blood cells","volume":"418","author":"Ohman","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.hlc.2023.03.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-007-9078-7","article-title":"P2 receptors in cardiovascular regulation and disease","volume":"4","author":"Erlinge","year":"2008","journal-title":"Purinergic Signal"},{"issue":"7","key":"10.1016\/j.hlc.2023.03.010_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","article-title":"Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans","volume":"61","author":"Wittfeldt","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2023.03.010_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCINTERVENTIONS.113.000293","article-title":"Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: an exploratory study","volume":"6","author":"Alexopoulos","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.hlc.2023.03.010_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000347122","article-title":"Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome","volume":"124","author":"Torngren","year":"2013","journal-title":"Cardiology"},{"issue":"20","key":"10.1016\/j.hlc.2023.03.010_bib10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hlc.2023.03.010_bib11","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hlc.2023.03.010_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jcmg.2012.08.007","article-title":"Coronary flow reserve during dipyridamole stress echocardiography predicts mortality","volume":"5","author":"Cortigiani","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hlc.2023.03.010_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004875","article-title":"Incremental value of transthoracic Doppler echocardiography-assessed coronary flow reserve in patients with suspected myocardial ischemia undergoing myocardial perfusion scintigraphy","volume":"6","author":"Gan","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2023.03.010_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/VHRM.S209003","article-title":"PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve","volume":"15","author":"Haraldsson","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.hlc.2023.03.010_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ejechocard\/jen174","article-title":"European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies","volume":"9","author":"Evangelista","year":"2008","journal-title":"Eur J Echocardiogr"},{"issue":"1","key":"10.1016\/j.hlc.2023.03.010_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2014.06.076","article-title":"Non-invasive evaluation of coronary flow reserve with transthoracic Doppler echocardiography predicts the presence of significant stenosis in coronary arteries","volume":"176","author":"Haraldsson","year":"2014","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.hlc.2023.03.010_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002649","article-title":"Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction","volume":"5","author":"Kato","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2023.03.010_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1475-2840-12-121","article-title":"Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease","volume":"12","author":"Kawata","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"19","key":"10.1016\/j.hlc.2023.03.010_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.hlc.2023.03.010_bib20","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/eurheartj\/ehr231","article-title":"Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes","volume":"32","author":"Storey","year":"2011","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hlc.2023.03.010_bib21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","article-title":"Adenosine, an endogenous distress signal, modulates tissue damage and repair","volume":"14","author":"Fredholm","year":"2007","journal-title":"Cell Death Differ"},{"issue":"22","key":"10.1016\/j.hlc.2023.03.010_bib22","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.116.024014","article-title":"Protective effects of ticagrelor on myocardial injury after infarction","volume":"134","author":"Vilahur","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.03.010_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2015.03.414","article-title":"Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study","volume":"187","author":"Bonello","year":"2015","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.hlc.2023.03.010_bib24","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","volume":"10","author":"Jeong","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2023.03.010_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fphys.2018.00337","article-title":"Ticagrelor improves endothelial function by decreasing circulating epidermal growth factor (EGF)","volume":"9","author":"Vieceli Dalla Sega","year":"2018","journal-title":"Front Physiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:08:08Z","timestamp":1761415688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950623001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1443950623001476"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.03.010","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}